TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Leishmaniasis Therapy
Data on leishmaniasis therapy published by investigators at Isfahan University of Medical Sciences, Research Center
December 30th, 2008
Scientists discuss in 'Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime' new findings in leishmaniasis. According to a study from Iran, "Antimonial compounds are regarded as the treatment of choice for cutaneous leishmaniasis (CL). Systemic administration of these drugs has some side effects including cardio toxicity and electrocardiogram (EKG) changes." "The objective of our study was to evaluate EKG changes in the patients with CL treated with systemic glucantime. One hundred and thirty-one patients were enrolled in this prospective study. All of the selected patients had confirmed CL and were candidates for...
Source: TB & Outbreaks Week (2008-12-30)
|
